Aveanna Healthcare Holdings Inc. · NASDAQ:AVAH
Aveanna Healthcare — Investor Presentation (August 2026)
21 slides from Aveanna Healthcare's investor presentation, Aug 13, 2026
Slide 1: Investor Presentation August 2026
Investor Presentation August 2026
Slide 2: Disclaimers and Forward-Looking Statements
Disclaimers and Forward-Looking Statements This investor presentation (this "presentation“) and any oral statements made in connection with this presentation are for information purposes only and do not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase a
Slide 3: Transforming the Value of Homecare
Transforming the Value of Homecare Aveanna offers a leading, diversified homecare platform that delivers innovative care to pediatric, adult, and geriatric patients. With locations in 39 states, Aveanna has established a national footprint dedicated to high-quality clinical outcomes and enhanced val
Slide 4: Management Team
Debbie Stewart Principal Accounting Officer Jeff Shaner Chief Executive Officer CEO of Aveanna since 2023 Instrumental in formation of Aveanna Healthcare Former Chief Operating Officer of Aveanna Healthcare Former Chief Operating Officer of PSA Healthcare Former SVP, President of Operations of Genti
Slide 5: Aveanna Overview
Aveanna Overview 2026 Guidance Key Operating Statistics (3) >$2.68b Revenue 32.2% Gross Margin(1) >$365m Adjusted EBITDA 403 Locations 39 States 30,000 Caregivers 48.9m Homecare Hours(2) 107 Preferred Payors ___________________________ 1. YTD 2026 Gross Margin 2. Annualized YTD 2026 PDS Hours 3. As
Slide 6: Aveanna's Transformative Homecare Platform
Melia and Mom Heather Valerie Aveanna's Transformative Homecare Platform Preferred Payor Partnerships Government Affairs Strategy Scaled National Platform Technology and Data Driven Results Reduction in Total Cost of Care Our advanced homecare platform positions us to improve outcomes with data-driv
Slide 7: Aveanna's Transformative Homecare Platform
Aveanna's Transformative Homecare Platform PDS Preferred Payors MS Preferred Payors Home Health Episodic Mix Value-based Agreements Continued substantial progress as demonstrated by key performance metrics. (1) ___________________________ 1. See Disclaimers and Forward-looking Statements slide. Proj
Slide 8: Aveanna's Transformative Homecare Platform: Growth
Melia and Mom Heather Valerie Growth will continue to be driven by organic growth, M&A, and the enhanced value derived from our significant investment in our national homecare platform. Aveanna's Transformative Homecare Platform Core Organic & Value Based Growth Scaled national platform drives growt
Slide 9: Aveanna Business Segments
Valerie Melia and Mom Heather Aveanna Business Segments
Slide 10: Private Duty Services Segment
Private Duty Services Segment Financial Highlights Key Operating Statistics (4) $2,179m Net Revenue1 26% – 28% Gross Margin2 5% – 6% Organic Growth Rate3 294 Locations 32 States 46,000 Patients on Service 64% % of PP Volume Preferred Payors 37 Preferred payor partnerships underpinned by enhanced rat
Slide 11: Home Health & Hospice Segment
Home Health & Hospice Segment Financial Highlights Key Operating Statistics (4) Locations States Patients on Service Episodic Mix Preferred Payors $271m Net Revenue1 50% – 52% Gross Margin2 8% – 10% Organic Growth Rate3 82 15 15,400 50 Home Health Geriatric Patient Population Intermittent Services S
Slide 12: Medical Solutions Segment
Medical Solutions Segment Financial Highlights Key Operating Statistics (4) States we deliver to Patients on Service Preferred Payors $186m Net Revenue1 42% – 44% Gross Margin2 8% – 10% Organic Growth Rate3 27 31,100 20 Nutritional Support – Enteral Product, Equipment and Supplies Provided to Pediat
Slide 13: Scaled Platform Built for Driving Growth and Enhancing Value
Scaled Platform Built for Driving Growth and Enhancing Value
Slide 14: Fragmented Home Care Markets Support Sustainable Growth
Fragmented Home Care Markets Support Sustainable Growth $21bn Legacy Pediatric TAM Hospice $33.0bn Enteral Nutrition $3.0bn Therapy $7.0bn Private Duty Nursing $11.0bn Home Health $37.0bn TAM Estimated annual growth from 2026-2031 $183bn ~6.5% Significant unmet demand with substantial opportunity to
Slide 15: Q2 2026 Financial Performance: Summary Results
Q2 2026 Financial Performance: Summary Results HHH Q2 2026 revenue growth of 14.8% from Q2 2025, driven by 14.7 thousand total episodes or 18.5% YOY volume increase PDS Q2 2026 revenue growth of 14.0% from Q2 2025, driven by 12.4 million hours of care or 12.3% YOY volume increase MS Q2 2026 revenue
Slide 16: Q2 2026 Financial Performance: Capital Structure
Q2 2026 Financial Performance: Capital Structure Liquidity of $432.7m, comprised of the following: $97.2m cash on balance sheet $225.5m revolver availability $110m securitization availability Undrawn revolver $24.5m in outstanding letters of credit Total variable rate debt of $1,483m, consisting of:
Slide 17: Path Forward: Strategic and Operational Focus on Driving Shareholder Value
Path Forward: Strategic and Operational Focus on Driving Shareholder Value Value Enhancing Acquisitions Core Organic Growth Enhanced Capital Structure
Slide 18: Appendix
8 aveanna healthcare Appendix 18
Slide 19: Non-GAAP Measures
Non-GAAP Measures Non-GAAP Financial Measures In addition to our results of operations prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”), we also evaluate our financial performance using EBITDA, Adjusted EBITDA, and Free cash flow. Given our determination of adj
Slide 20: Reconciliation of Net Income to Adjusted EBITDA
Reconciliation of Net Income to Adjusted EBITDA ___________________________ 1-8: Please see our earnings release posted on August 13, 2026 for further description of the nature of these items
Slide 21: Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow
Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow
Aveanna Healthcare Holdings — Investor Presentation (August 2026) on 6ix